Intellia Therapeutics, Inc. short interest in 2020
In 2020, Intellia Therapeutics, Inc.'s disclosed short interest ran from 19.54% of shares outstanding on 15 Jan 2020 to 17.18% on 31 Dec 2020, a change of -2.36 percentage points. The year's high was 21.99% on 15 Apr 2020 and its low 17.18% on 31 Dec 2020, averaging 20.36% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.00 days on 31 Aug 2020. Full history: Intellia Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 19.54% (15 Jan 2020)
- End of year
- 17.18% (31 Dec 2020)
- Change
- -2.36 pp
- High
- 21.99% (15 Apr 2020)
- Low
- 17.18% (31 Dec 2020)
- Average
- 20.36%
- Highest days to cover
- 20.00 (31 Aug 2020)
- SEC filings marked
- 9
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 19.54% | 18.23 | results (8-K) |
| 31 Jan 2020 | 20.86% | 19.04 | |
| 14 Feb 2020 | 21.24% | 18.40 | |
| 28 Feb 2020 | 21.52% | 13.63 | 10-K filed, results (8-K) |
| 13 Mar 2020 | 21.80% | 10.60 | |
| 31 Mar 2020 | 21.31% | 13.72 | |
| 15 Apr 2020 | 21.99% | 19.66 | |
| 30 Apr 2020 | 21.20% | 17.13 | |
| 15 May 2020 | 20.64% | 13.38 | 10-Q filed, results (8-K) |
| 29 May 2020 | 21.04% | 11.74 | |
| 15 Jun 2020 | 19.52% | 6.81 | |
| 30 Jun 2020 | 21.76% | 12.01 | |
| 15 Jul 2020 | 20.79% | 12.60 | |
| 31 Jul 2020 | 18.34% | 19.69 | |
| 14 Aug 2020 | 18.66% | 15.96 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 18.53% | 20.00 | |
| 15 Sep 2020 | 18.99% | 14.44 | |
| 30 Sep 2020 | 20.32% | 15.38 | |
| 15 Oct 2020 | 21.78% | 10.33 | |
| 30 Oct 2020 | 21.81% | 15.05 | |
| 13 Nov 2020 | 21.31% | 15.49 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 19.80% | 13.55 | |
| 15 Dec 2020 | 18.69% | 6.31 | |
| 31 Dec 2020 | 17.18% | 5.64 |
See also: Intellia Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.